the use case / value proposition for IHL-675A gets stronger month by month the deeper into the research we go...
La Trobe has it going on
world leading /best in class research imo, ..... vaccines were always a short term solution only -
14/06/21
and prior to ICU ..and any required patient intubation - as a potential prophylactic pro active / pre emptive treatment -
all the research and empirical evidence to date indicates major damage has potentially already been incurred by the time ICU has been required...
if timing is everything then what IHL-675A potentially brings to the table can't come soon enough imo
news eagerly awaited as always - and it will be company making imo
GLA
the use case / value proposition for IHL-675A gets stronger...
-
- There are more pages in this discussion • 13,961 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)